Using the WARIFA app to promote healthy lifestyles and manage Type 1 Diabetes
Effect of the WARIFA App on User-defined Objectives, Healthy Lifestyles and Management of Type 1 Diabetes: a Pilot Randomised Controlled Trial
NA · Instituto Universitario de Investigaciones Biomédicas y Sanitarias (iUIBS) de la Universidad de Las · NCT06918444
This study is testing whether the WARIFA app can help people with Type 1 Diabetes and those with other health conditions live healthier lives by giving them personalized tips.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 104 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Instituto Universitario de Investigaciones Biomédicas y Sanitarias (iUIBS) de la Universidad de Las (other) |
| Locations | 1 site (Las Palmas de Gran Canaria, Las Palmas) |
| Trial ID | NCT06918444 on ClinicalTrials.gov |
What this trial studies
This study evaluates the WARIFA app's effectiveness in encouraging healthy lifestyle behaviors and managing Type 1 Diabetes (T1D) through personalized recommendations based on user-generated data and artificial intelligence. Participants will be divided into two groups: the general population with no more than one non-communicable disease (NCD) and individuals with T1D. The study aims to assess both the impact of the app on health outcomes and the feasibility of implementing such a health intervention. Outcomes will be measured to determine the app's effectiveness in promoting health and preventing NCDs.
Who should consider this trial
Good fit: Ideal candidates include adults over 18 years old with either Type 1 Diabetes or no more than one non-communicable disease, who own an Android smartphone with internet access.
Not a fit: Patients with two or more non-communicable diseases or those unable to use the app due to language barriers or incompatible devices may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could significantly improve lifestyle management and health outcomes for individuals with Type 1 Diabetes and those at risk of non-communicable diseases.
How similar studies have performed: While there have been studies on mobile health interventions, the specific use of the WARIFA app with AI for this purpose is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Common for both population groups: * Adults over 18 years of age. * Owners of a smartphone operating with Android and with internet access. * Group 1: General population: * Healthy or diagnosed with no more than one NCD (CVD, any type of cancer, T2D or chronic respiratory disease). * Group 2: T1D: * Treatment with multiple subcutaneous insulin injections or an insulin pump. * Users of a continuous glucose monitor. Exclusion Criteria: * Common for both groups: * Pregnancy. * Mobile device which is incompatible with the WARIFA app (E.g. Apple devices). * Unable to understand any of the app languages (Spanish, English, Norwegian or Romanian). * Any reason which precludes follow-up, based on the researcher's criteria. * Group 1: General population * People with two or more NCDs.
Where this trial is running
Las Palmas de Gran Canaria, Las Palmas
- Instituto Universitario De Investigaciones Biomédicas y Sanitarias (IUIBS) — Las Palmas de Gran Canaria, Las Palmas, Spain (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Lifestyle Intervention, Non Communicable Chronic Diseases, Type 1 Diabetes, AI, Mobile app, Lifestyle intervention, Risk Prediction Model